维普中文期刊产品整合服务
13篇 您的检索式:作者名="Hirbe AC"
    题名 作者 年代 出处 被引量
1Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone 显示文摘Hirbe AC Rubin J Uluckan O 2007Proc Natl Acad Sci USA2007,104,14:1
2The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts 显示文摘Hirbe AC Roelofs AJ Floyd DH 2009Bone2009,44,5:1
3Functional analysisof neurofibromatosis 2 (NF2) missense mutations显示文摘Gutmann DH Hirbe AC Haipek CA 2001Hum Mol Genet2001,10,14:1
4RelB is the NF-kappaB sub-unit downstream of NIK responsible for osteoclast differentiation显示文摘Vaira S Johnson T Hirbe AC 2008Proc Natl Acad Sci USA2008,10,:1
5The CXCR4/SDF -1 chemokine axis : a potential therapeutic target for bone metastases?显示文摘Hirbe AC Morgan KN Weilbaecher 2010Curr Pharm Des2010,16,11:1
6Functional analysis of neurofibromatosis 2 (NF2) missense mutations 显示文摘 Hirbe AC Haipek CA 2001Hum Mol Genet2001,10,14:1
7Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner显示文摘Hirbe AC Uluckan O Morgan EA 2007Blood2007,109,8:1
8Neurofibromatosis type 1: a multidisciplinary approach to care显示文摘HIRBE AC GUTMANN DH 2014Lancet Neurol2014,13,8:1
9Rel B is the NF-kappa B subunit downstream of NIK responsible for osteoclast differentiation显示文摘Vaira S Johnson T Hirbe AC 2008Proc Natl Acad Sci USA2008,105,10:1
10RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation显示文摘Vaira S Johnson T Hirbe AC 0,,:1
11Functional analy sis of neurofibromatosis 2 (NF2) missense mutations显示文摘Gutmann DH Hirbe AC Haipek CA 0,,:1
12The CXCR4/SDF-I che- mokine axis:a potential therapeutic target for bone metastases? 显示文摘Hirbe AC Morgan EA Weilbaecher KN 2010Curr Pharm Des2010,16,11:1
13Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone 显示文摘Hirbe AC Rubin J Ulu kan O 2007Proc Natl Acad Sci U S A2007,104,14:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费